WARREN, N.J., Sept. 12, 2024 /PRNewswire/ — PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that on Sept. 8, 2024, the company approved non-statutory stock options to purchase an aggregate of 16,180 shares of its common stock and 23,725 restricted stock units (“RSUs”), each representing the right to receive one share of its common stock upon vesting, to nine new employees. The awards were made pursuant to the Nasdaq inducement grant exception as a component of the new hires’ employment compensation.
The inducement grants were approved by PTC’s Compensation Committee on Sept. 8, 2024, and are being made as an inducement material to each employee’s acceptance of employment with the company in accordance with Nasdaq Listing Rule 5635(c)(4).
All stock option awards have an exercise price of $31.54 per share, the closing price of PTC’s common stock on Sept. 6, 2024, the immediately preceding trading day. The stock options…